Endothelial dysfunction defined as a loss of biologically active nitric oxide (NO) produced in the endothelium, is one of the most important events in initiation and progression of vascular disease. Tetrahydrobiopterin (BH4) is an essential cofactor needed for enzymatic activity of nitric oxide synthase(s) and biosynthesis of NO. In vivo mechanisms responsible for the control of BH4 metabolism are poorly understood. During preliminary studies for this application we identified erythropoietin (EPO) as a novel and potent stimulator of BH4 biosynthesis in the cardiovascular system. EPO is circulating hormone responsible for control of erythropoiesis, however, more recent findings suggest that EPO has important non-erythropoietic effects including vascular protection. The general hypothesis of this proposal is that in vivo, BH4 critically contributes to the vascular protective effect of EPO. To test this hypothesis we propose studies with following specific aims: 1) determine the role of BH4 in mediation of protective effectsof EPO in vascular endothelium, 2) determine if EPO may prevent development of atherosclerosis, and 3) analyze the mechanisms of EPO- induced endothelial repair after vascular injury. In vivo genetic and pharmacological approaches will be used to manipulate levels of circulating EPO and BH4. Established murine models of endothelial dysfunction and vascular injury will be employed to determine role of BH4 in mediation of vascular protective effects of EPO. To dissect direct effects of EPO from its rheological effects due to increase in shear stress imposed on endothelium by circulating erythrocytes, effects of novel non-erythropoietic derivatives of EPO will be studied. It is anticipated that the results of the proposed experiments will provide novel and important information concerning the role of EPO in control of BH4 metabolism in the cardiovascular system. This information may help to develop new strategies in prevention and treatment of endothelial dysfunction. .

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL053524-13
Application #
7584083
Study Section
Vascular Cell and Molecular Biology Study Section (VCMB)
Program Officer
Goldman, Stephen
Project Start
1994-12-01
Project End
2011-03-31
Budget Start
2009-04-01
Budget End
2011-03-31
Support Year
13
Fiscal Year
2009
Total Cost
$323,343
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Santhanam, Anantha Vijay R; d'Uscio, Livius V; He, Tongrong et al. (2012) PPAR? agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice. Brain Res 1483:89-95
He, Tongrong; Smith, Leslie A; Lu, Tong et al. (2011) Activation of peroxisome proliferator-activated receptor-{delta} enhances regenerative capacity of human endothelial progenitor cells by stimulating biosynthesis of tetrahydrobiopterin. Hypertension 58:287-94
Santhanam, Anantha Vijay R; Smith, Leslie A; Katusic, Zvonimir S (2010) Brain-derived neurotrophic factor stimulates production of prostacyclin in cerebral arteries. Stroke 41:350-6
Austin, Susan A; Santhanam, Anantha V; Katusic, Zvonimir S (2010) Endothelial nitric oxide modulates expression and processing of amyloid precursor protein. Circ Res 107:1498-502
d'Uscio, Livius V; Smith, Leslie A; Katusic, Zvonimir S (2010) Erythropoietin increases expression and function of vascular copper- and zinc-containing superoxide dismutase. Hypertension 55:998-1004
He, Tongrong; Joyner, Michael J; Katusic, Zvonimir S (2009) Aging decreases expression and activity of glutathione peroxidase-1 in human endothelial progenitor cells. Microvasc Res 78:447-52
Peterson, Timothy E; d'Uscio, Livius V; Cao, Sheng et al. (2009) Guanosine triphosphate cyclohydrolase I expression and enzymatic activity are present in caveolae of endothelial cells. Hypertension 53:189-95
Katusic, Zvonimir S; d'Uscio, Livius V; Nath, Karl A (2009) Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. Trends Pharmacol Sci 30:48-54
Santhanam, Anantha Vijay R; d'Uscio, Livius V; Peterson, Timothy E et al. (2008) Activation of endothelial nitric oxide synthase is critical for erythropoietin-induced mobilization of progenitor cells. Peptides 29:1451-5
He, Tongrong; Lu, Tong; d'Uscio, Livius V et al. (2008) Angiogenic function of prostacyclin biosynthesis in human endothelial progenitor cells. Circ Res 103:80-8

Showing the most recent 10 out of 77 publications